Support

Lorem ipsum dolor sit amet:

24h / 365days

We offer support for our customers

Mon - Fri 8:00am - 5:00pm (GMT +1)

Get in touch

Cybersteel Inc.
376-293 City Road, Suite 600
San Francisco, CA 94102

Have any questions?
+44 1234 567 890

Drop us a line
info@yourdomain.com

About us

Lorem ipsum dolor sit amet, consectetuer adipiscing elit.

Aenean commodo ligula eget dolor. Aenean massa. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Donec quam felis, ultricies nec.

DISTRIBUCIÓN

Distribución

¿Es el socio de distribución adecuado? - Seleccionar el
distribuidor designado

¿Qué negocios complementarios generan sinergias? ¿Quién puede ser el distribuidor adecuado para mi producto? ¿Cuántos socios necesito y qué cobertura tienen? ¿Cuál es su potencial de venta de tecnología diferencial frente al
precio? ¿Qué obstáculos legales debo evitar en el acuerdo de distribución designado en cada mercado?

Nos asociamos con numerosos distribuidores de primera clase desde hace varios años. Nuestra experiencia es su
filtro y su garantía para obtener una asociación exitosa. Para soluciones específicas buscamos e identificamos para
usted el distribuidor adecuado. Negociamos precios de transferencia justos, pronosticamos cifras de ventas fiables
y definimos cifras de compra mínimas al año. Fijamos un acuerdo de distribución adecuado para usted con su
distribuidor seleccionado.

 

Milestones

Doctor Ulises Rojel Martinez, president of the Latin American Heart Rhythm Society

The teams of i2medi -the official distributor of impulse dynamics (the CCM manufacturer) in Mexico
have been successfully trained and certified in Feb 2024.

The teams of i2medi -the official distributor of impulse dynamics (the CCM manufacturer) in Mexico
have been successfully trained and certified in Feb 2024.

Since April 2023, i²medi S.A.S., based in Colombia, has been acting as an official importer of controlled and non-controlled medical devices in the Colombian market.

The Brazilian Society of Cardiology recommends Cardiac Contractility Modulation (CCM) therapy as an option for the treatment of heart failure patients without indication for CRT, with narrow QRS (< 130 ms) and LVEF between 25% and 45%.

Successful user training course for 59 participants on R.E.M.S. technology with ...

i2medi has managed to successfully conclude the first contract with the most modern hospital for the treatment of cancer in LATAM (CTIC).

i2medi has launched the distribution of cardiac contractility modulation in Brazil ...

i2medi, together with its local strategic partners, organized a major launch event at the ...

Sustainable and strategic product positioning in the key markets of Latin America (BRA, COL and MEX)

Copyright 2024. All Rights Reserved.
Datenschutzeinstellungen
You are using an outdated browser. The website may not be displayed correctly. Close